A5007658785- Diabetes Management and Research
- Diabetes Treatment and Management
- Diabetes Management and Education
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Metabolism, Diabetes, and Cancer
- Pancreatic function and diabetes
- Diet and metabolism studies
- Diabetes and associated disorders
- Bariatric Surgery and Outcomes
- Pituitary Gland Disorders and Treatments
- Thyroid Cancer Diagnosis and Treatment
- Pharmacology and Obesity Treatment
- Adrenal Hormones and Disorders
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Thyroid Disorders and Treatments
- Hormonal Regulation and Hypertension
- Pregnancy and preeclampsia studies
- Diet, Metabolism, and Disease
- Growth Hormone and Insulin-like Growth Factors
- Neuroendocrine Tumor Research Advances
- Gestational Diabetes Research and Management
- Bone health and osteoporosis research
- Adrenal and Paraganglionic Tumors
- Liver Disease Diagnosis and Treatment
- Obesity and Health Practices
Indraprastha Apollo Hospitals
2022-2025
Pacific Northwest National Laboratory
2024-2025
Weatherford College
2024
Saifee Hospital
2020-2024
Battelle
2024
Lupin Pharmaceuticals (India)
2024
All India Institute of Medical Sciences Bhubaneswar
2024
Christian Medical College & Hospital
2024
Bharti Hospital
2022-2024
University of Kalyani
2024
Glucocorticoids are potent immunosuppressive and anti-inflammatory drugs used for various systemic localized conditions. The use of glucocorticoids needs to be weighed against their adverse effect aggravating hyperglycemia in persons with diabetes mellitus, unmask undiagnosed or precipitate glucocorticoid-induced mellitus appearance. Hyperglycemia is associated poor clinical outcomes, including infection, disability after hospital discharge, prolonged stay, death. Furthermore, clear...
Abstract: Diabetes and obesity are both increasing at a fast pace giving rise to new epidemic called diabesity. Lifestyle interventions including diet play major role in the treatment of diabetes, There many guidelines on dietary management diabetes or globally also from South Asia. However, there no global Asian non-pharmacological Asia differs rest world as Asians have different phenotype, cooking practices, food resources exposure, medical nutrition therapy (MNT) availability trained...
An accelerated atherosclerotic process is a significant contributor to the development of vascular complications in diabetes. Endothelial dysfunction and heightened platelet hyperactivity diabetes exacerbate vasoconstriction thrombus formation, thereby accelerating process. The hyperreactivity associated with prothrombotic state characterised by alterations morphology function. Platelet indices, such as volume, distribution width, platelet-large cell ratio plateletcrit, reflect these...
Diabetes and obstructive sleep apnoea (OSA) are interconnected chronic conditions. The increasing prevalence of obesity drives the pathogenesis these interrelated disorders. OSA, characterised by nocturnal hypoxia resulting from recurrent episodes upper airway obstruction during sleep, is common in individuals with type 2 diabetes mellitus (T2DM). At same time, T2DM increases risk OSA through mechanisms involving obesity, systemic inflammation, autonomic dysfunction. insulin resistance,...
Type 2 diabetes mellitus (T2DM) affects bone health, increasing the risk of fracture despite normal or elevated mineral density (BMD). This paradox is attributed to impaired quality, microarchitectural defects and advanced glycation end-products-related damage. Additionally, complications diabetes, such as neuropathy, retinopathy medication side effects, contribute increased fall risk. Traditional diagnostic tools like dual-energy X-ray absorptiometry Fracture Risk Assessment Tool → often...
Type 1 diabetes mellitus (T1DM) is a chronic autoimmune condition characterized by the irreversible destruction of β cells pancreas, which leads to lifelong dependency on exogenous insulin. Despite advancements in insulin delivery methods, suboptimal outcomes these methods have triggered search for therapies that may prevent or reverse disease. Given aetiology T1DM, counteracting immune-mediated β-cells are obvious target. Although several treatment strategies been attempted target cellular,...
The landscape of type 2 diabetes mellitus (T2DM) management is evolving with the emergence imeglimin alongside longstanding use metformin. While both drugs share structural similarities and target mitochondrial complex I, they exhibit distinct mechanisms action therapeutic effects. Imeglimin, its modulation competitive inhibition holds promise in mitigating beta-cell dysfunction, improving insulin sensitivity, offering potential cardiovascular benefits. Efficacy studies suggest comparable...